Maternal Postpartum Stress Scale: Translation and validation study of the Chinese version

Yanchi Wang; Qian Gao; Jin Liu; Feng Zhang; Xujuan Xu

doi:10.1101/2023.07.31.23293354

Abstract

Objective This study aimed to translate the Maternal Postpartum Stress Scale (MPSS) into Chinese and validate its psychometric properties in postpartum women.

Methods A total of 406 postpartum women were recruited from 6 hospitals in Nantong, Jiangsu, China. Cronbach’s α co-efficient, split-half reliability, and test-retest reliability were used to evaluate the reliability of the translated scale. Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) were used to evaluate the structural validity of the scale. The Edinburgh Postpartum Depression Scale (EPDS), the anxiety subscale of the Depression-Anxiety-Stress Scale (DASS-21) and the Perceived Stress Scale (PSS-10) were used as calibration scales to measure the correlation of MPSS.

Results The Cronbach’s α co-efficient of the Chinese version of MPSS was 0.940 and the Cronbach’s α co-efficient of the three subscales ranged from 0.882 to 0.911. The split-half reliability was 0.825, and the test-retest reliability was 0.912. The content validity index of the scale (S-CVI) was 0.926. A total of three common factors were extracted from the EFA. The CFA validated the explored 3-factor structure, and the indicators fitted well (χ²/df = 2.167, comparative fit index = 0.918, tucker-lewis index=0.907, incremental fit index=0.919 and root mean square error of approximation = 0.075).

Conclusion With superb reliability and validity, the Chinese version of MPSS can be used to assess postpartum stress in Chinese women, which is expected to lay a scientific basis for the early identification of postpartum women’s stress, thus providing a basis for the development of early individualized interventions. Equally importantly, with specific clinical value and practical significance for postpartum women’s physical and mental health, future replication studies of the Chinese version of MPSS should be carried out in diverse samples and clinical populations.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by Social Science Foundation of Jiangsu Province (22SHB014).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was reviewed and approved by the Ethics Committee of Affiliated Hospital of Nantong University (approval number: 2022-K50-01)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes